Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Item 9 Labs (INLB) Capital Expenditures (2018 - 2023)

Item 9 Labs' Capital Expenditures history spans 9 years, with the latest figure at $62845.0 for Q2 2023.

  • For Q2 2023, Capital Expenditures rose 820.81% year-over-year to $62845.0; the TTM value through Jun 2023 reached $2.2 million, down 31.03%, while the annual FY2022 figure was $4.3 million, 93.0% up from the prior year.
  • Capital Expenditures reached $62845.0 in Q2 2023 per INLB's latest filing, down from $1.4 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $3.9 million in Q2 2019 to a low of -$3.3 million in Q3 2019.
  • Average Capital Expenditures over 5 years is $573947.7, with a median of $240108.0 recorded in 2021.
  • Peak YoY movement for Capital Expenditures: plummeted 1336.69% in 2019, then skyrocketed 6754.78% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at $42350.0 in 2019, then surged by 1079.34% to $499452.0 in 2020, then skyrocketed by 399.04% to $2.5 million in 2021, then crashed by 43.47% to $1.4 million in 2022, then crashed by 95.54% to $62845.0 in 2023.
  • Per Business Quant, the three most recent readings for INLB's Capital Expenditures are $62845.0 (Q2 2023), $1.4 million (Q3 2022), and $6825.0 (Q2 2022).